Results 101 to 110 of about 1,428 (167)

Trends in sodium-glucose transport protein 2 inhibitor prescriptions: application of the ATC/DDD system to NDB open data. [PDF]

Diabetol Int
Miyake T, Hashimoto M, Kadowaki D.
europepmc   +1 more source

Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial. [PDF]

Diabetes Ther
Kimura K, Takagi Y, Harada M, Ueda S, Minamisawa M, Sonoda K, Oiwa A, Yazaki Y, Sakurai S, Tomita T, Kaneko K, Yamamoto K, Takama N, Momose S, Inobe Y, Nogi K, Koshikawa M, Misawa T, Kasai T, Tsutsui H, Watanabe N, Yamazaki K, Miyamoto T, Midorikawa T, Usui T, Saigusa T, Motoki H, Saito Y, Kamijo Y, Komatsu M, Kuwahara K.   +30 more
europepmc   +1 more source

Effect of tofogliflozin on obesity-related health problems in patients with type 2 diabetes and overweight or obesity-a post-hoc sub-analysis of the UTOPIA study. [PDF]

Diabetol Int
Katakami N, Mita T, Masuda T, Sato Y, Watada H, Shimomura I.   +5 more
europepmc   +1 more source

Impact of SGLT2 Inhibitors on Mortality Across Different Populations: A Systematic Review and Meta-Analysis. [PDF]

Int J Mol Sci
Movila DE, Motofelea AC, Dragan SR, Schiller A, Ionac A, Motofelea N, Caruntu F.   +6 more
europepmc   +1 more source

Sodium-glucose cotransporter 2 inhibitors for diabetic neuropathy: a protocol for a systematic review and meta-analysis. [PDF]

BMJ Open
Tao W, Yu Y, Huang X, Huang J, Wu X, Yu R, Xiao F.   +6 more
europepmc   +1 more source

Efficacy and Safety of SGLT2 Inhibitors and Sotagliflozin in Heart Failure: A Systematic Review and Meta-Analysis of 59 Randomized Controlled Trials. [PDF]

Cureus
Muller Ferreira V, Ayres Muller V.
europepmc   +1 more source

SO019RENAL AUTONOMIC NERVES ARE RESPONSIBLE FOR BODY WEIGHT REDUCTION BY TOFOGLIFLOZIN [PDF]

Nephrology Dialysis Transplantation, 2016
openaire   +1 more source

SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Tantush A, Ben Hamida B, Sagher M, Afsheen N, Sager M, Abusbaeh A, Tantoush M, Abusbaeh A, Najaim A, Alhamadi M, Hesham Gamal M, Alemam MM, Elhady MM.   +12 more
europepmc   +1 more source

Comparative Efficacy of SGLT2 Inhibitors in MASLD: Bayesian Network Meta-Analysis of CAP-LSM Outcomes and Time Effects. [PDF]

JGH Open
Gomez DP, Hababag WF, Ong-Ramos CC.
europepmc   +1 more source

Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. [PDF]

Cureus
Sato S, Yoshimura T, Komori K, Saheki T, Kobayashi T, Fukunaga K, Imachi H, Murao K.   +7 more
europepmc   +1 more source